CD68 and metabolic dysfunction-associated steatohepatitis: Thus, the CCl4 accelerates the WD-related hepatic injury, enhancing HSC activation and collagen deposition, whereas increasing CD68+ cell density, a well-known potential driver of NASH, was a C57BL/6J strain-specific event, indicating potential dissimilar mechanisms of developing NASH in mouse strains.